CORONAVIRUS/Taiwan approves remdesivir as COVID-19 medication
Taipei, May 30 (CNA) Taiwan's health authorities have approved the potential new coronavirus COVID-19 medication remdesivir for treatment of the disease in the country, the Central Epidemic Command Center said Saturday.
At a daily press briefing, Wu Shou-mei (吳秀梅), Director-General of Taiwan's Food and Drug Administration (FDA), said that a panel of experts which met on Friday found that the drug was needed in Taiwan and agreed that it should be used to treat severe patients infected with COVID-19.
Taiwan plans to order doses for 1,000 patients, with the order expected to arrive late July, Wu said, adding that the move is to ensure there is enough medication for severely ill patients if a second wave of infection occurs.
The expert panel came to a consensus that remdesivir can be approved in Taiwan under Article 48-2 of the Pharmaceutical Affairs Act, which states that the drug can be manufactured or imported as a "special case," Wu said.
The longest period of treatment with remdesivir will be 10 days, with different dosages for people of different weights, Wu added.
After the drug is available for use, the suppliers will still need to implement a risk management plan to ensure patient safety, Wu said.
"At the moment, even though clinical testing is still being carried out, it (remdesivir) is the drug we have seen so far that shows more promising results," Wu said.
Due to the emergency of the situation, Taiwan needs to quickly approve the drug for its patients, Wu said.
Remdesivir was given an emergency use authorization in the United States on May 1 and was also given a special approval for emergencies in Japan on May 7, Wu said.
Taiwan's FDA received an application by remdesivir's supplier on May 25, and will officially issue a permit for the drug sometime next week, Wu said.
The broad-spectrum antiviral medication, developed by American-based biopharmaceutical company Gilead Sciences, Inc., has made headlines around the world as gaining emergency authorization in countries treating patients infected with the coronavirus.
To date, Taiwan has recorded 442 cases of the disease, with seven deaths, the CECC has reported.
- German companies in Taiwan troubled by travel bans: surveyAn overwhelming majority of German companies operating in Taiwan consider travel restrictions between Taiwan and the European Union harmful to their businesses, a survey by the ...07/06/2020 10:12 PM
- Health experts push COVID-19 testing for all inbound passengersPublic health experts on Monday called for Taiwan to allow all incoming passengers to be given the option of testing for COVID-19 instead of just following the current 14-day ...07/06/2020 07:36 PM
- Filipina transfer passenger no major COVID-19 threat to Taiwan: CECCA Filipina who tested positive for COVID-19 Saturday in Hong Kong after transiting through Taiwan a day earlier does not pose a major threat to the country, the Central Epidemic ...07/06/2020 12:14 PM
Hon Hai Q2 sales bounce back to top NT$1 trillion07/07/2020 02:56 PM
Taiwan headline news07/07/2020 02:17 PM
Taiwan shares close down 0.2%07/07/2020 01:48 PM
Unstable weather forecast until Thursday07/07/2020 12:03 PM
Forex reserves hit new high amid rare admission of market intervention07/07/2020 11:52 AM